Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Zajicek

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neurochemistry International|June 16, 2011
Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's diseaseC B Carroll, M-L Zeissler, N Chadborn, et al.
Journal of Neurology|February 20, 2008
Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosisC L Hirst, A Pace, T P Pickersgill, et al.
Brain : a Journal of Neurology|November 11, 2005
Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)J C Hobart, A Riazi, A J Thompson, et al.
Neurology|October 13, 2004
Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover studyC B Carroll, P G Bain, L Teare, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJ P Zajicek, H P Sanders, D E Wright, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Central nervous system sarcoidosis--diagnosis and managementJ P Zajicek, N J Scolding, O Foster, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neurochemistry International|June 16, 2011
Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's diseaseC B Carroll, M-L Zeissler, N Chadborn, et al.
Journal of Neurology|February 20, 2008
Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosisC L Hirst, A Pace, T P Pickersgill, et al.
Brain : a Journal of Neurology|November 11, 2005
Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)J C Hobart, A Riazi, A J Thompson, et al.
Neurology|October 13, 2004
Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover studyC B Carroll, P G Bain, L Teare, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJ P Zajicek, H P Sanders, D E Wright, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Central nervous system sarcoidosis--diagnosis and managementJ P Zajicek, N J Scolding, O Foster, et al.
Pageof 2